GlassScriptPhysician profile
Kenneth W Hahn
NPI 1922005818
$19,715.76
in general payments reported to CMS, 2019-2025
83 companies · $2,786 in 2025
The $2,786 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,861 · 2020: $2,657 · 2021: $3,623 · 2022: $2,659 · 2023: $2,371 · 2024: $2,759 · 2025: $2,786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,916.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,727.62 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,219.12 | 2019-2025 | Airsupra, Nexium, Breztri |
| Novo Nordisk INC | $2,018.60 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,379.59 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $1,187.36 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $1,019.82 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $944.66 | 2019-2025 | |
| Amgen INC. | $908.70 | 2019-2025 | Repatha, Evenity, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $577.12 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $496.18 | 2019-2025 | Xarelto, Spravato |
| Merck Sharp & Dohme LLC | $464.55 | 2019-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Novartis Pharmaceuticals Corporation | $407.44 | 2019-2025 | |
| Astellas Pharma US INC | $381.05 | 2019-2024 | Veozah |
| Sanofi-Aventis U.S. LLC | $373.24 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $287.31 | 2019-2025 | Xifaxan, Trulance |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $284.72 | 2021-2025 | Freestyle Libre 3, Proclaim, Eterna |
| Medtronic, INC. | $239.43 | 2021-2022 | |
| Allergan, INC. | $219.21 | 2019-2022 | |
| Horizon Therapeutics Plc | $187.93 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $181.27 | 2022 | |
| Eisai INC. | $179.72 | 2020-2025 | |
| Grifols USA, LLC | $157.72 | 2019-2025 | Prolastin-C Liquid |
| Teva Pharmaceuticals USA, INC. | $156.66 | 2019-2024 | Ajovy, Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $154.79 | 2019-2025 | Glassia |
| Otsuka America Pharmaceutical, INC. | $148.45 | 2019-2024 | Rexulti |
| Amarin Pharma, INC. | $120.89 | 2019-2021 | |
| Exact Sciences Corporation | $116.66 | 2023-2025 | Cologuard Collection Kit |
| Cranial Technologies, INC | $111.88 | 2019-2025 | Doc Band |
| Hologic Sales and Service, LLC | $104.30 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Nestle Healthcare Nutrition INC. | $103.36 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $86.61 | 2021 | |
| Optinose US, INC. | $80.23 | 2020-2022 | |
| Seqirus USA INC | $74.53 | 2019-2025 | Fluad, Flucelvax |
| Esperion Therapeutics, INC. | $74.26 | 2021 | |
| Lucid Diagnostics INC. | $68.25 | 2021 | |
| Vanda Pharmaceuticals INC. | $67.26 | 2023 | Hetlioz, Fanapt |
| Corium, LLC | $66.39 | 2023-2024 | Azstarys |
| Ibsa Pharma INC. | $64.89 | 2019-2025 | Flector, Licart, Tirosint |
| E.R. Squibb & Sons, L.L.C. | $63.84 | 2019-2020 | |
| Edwards Lifesciences Corporation | $58.80 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Idorsia Pharmaceuticals US INC | $47.70 | 2023-2024 | Quviviq |
| Dexcom, INC. | $47.01 | 2024 | Dexcom G6 Transmitter |
| Ironshore Pharmaceuticals INC. | $46.37 | 2020 | |
| Daiichi Sankyo INC. | $44.19 | 2021-2022 | |
| Biogen, INC. | $44.18 | 2019-2021 | |
| Corcept Therapeutics | $41.41 | 2021-2025 | Korlym |
| Aimmune Therapeutics, INC. | $39.45 | 2024-2025 | Zenpep |
| Jazz Pharmaceuticals INC. | $38.25 | 2019-2020 | |
| Cleerly, INC. | $37.64 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Therapeuticsmd, INC. | $37.03 | 2019-2020 | |
| Medtronic Minimed, INC. | $35.99 | 2019 | |
| Dermira, INC. | $35.67 | 2020 | |
| Gilead Sciences, INC. | $34.59 | 2019-2020 | |
| Heartflow, INC. | $33.83 | 2022-2025 | |
| Sanofi Pasteur INC. | $31.02 | 2021-2022 | |
| Inogen, INC. | $27.43 | 2022 | |
| Coopersurgical, INC. | $26.18 | 2021-2023 | Paragard T 380a |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.88 | 2025 | Caplyta |
| Alexion Pharmaceuticals, INC. | $25.66 | 2023 | Strensiq |
| Organon LLC | $23.84 | 2025 | Nexplanon |
| Abiomed | $23.35 | 2024 | Impella |
| Ani Pharmaceuticals, INC. | $23.00 | 2025 | Purified Cortrophin Gel |
| Shire North American Group INC | $22.90 | 2019 | |
| Qol Medical, LLC | $22.68 | 2022 | |
| Ossur Americas, INC. | $22.65 | 2025 | |
| Xeris Pharmaceuticals, INC. | $22.28 | 2025 | Gvoke Hypopen |
| Vbi Vaccine (Delaware) INC. | $22.21 | 2022 | |
| Boston Scientific Corporation | $22.05 | 2025 | General - Therapies |
| Assertio Therapeutics, INC. | $22.04 | 2019 | |
| Electromed, INC. | $21.03 | 2025 | Smartvest |
| Lexicon Pharmaceuticals, INC. | $20.61 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $18.72 | 2024 | Bd Onclarity |
| Kaleo, INC. | $18.16 | 2022 | |
| Medtronic USA, INC. | $17.52 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $17.02 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.83 | 2023 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $16.63 | 2025 | Uptravi, Opsumit |
| Neos Therapeutics, LP | $15.98 | 2019 | |
| Medtronic Vascular, INC. | $14.45 | 2020 | |
| Tactile Systems Technology INC | $13.44 | 2021 | |
| Linus Health, INC. | $12.04 | 2024 | Core Cognitive Evaluation |
| Lupin INC. | $11.40 | 2019 | |
| Dysis Medical, INC. | $11.04 | 2020 |
Drugs and devices associated with these payments
Vraylar $857Jardiance $622Nurtec Odt $470Kerendia $407Rybelsus $389Trelegy Ellipta $374Zavzpret $373Airsupra $354Mounjaro $341Ozempic $336Qulipta $295Ubrelvy $251Repatha $222Nexium $188Otezla $184Freestyle Libre 3 $179Veozah $169Zepbound $160Tzield $156Evenity $155Xifaxan $149Paxlovid $143Shingrix $130Cologuard Collection Kit $117Rexulti $111Wegovy $108Breztri $105Linzess $93.57Trulance $90.13Gardasil 9 $87.39Capvaxive $86.31Doc Band $79.20Leqembi $78.41Comirnaty $76.83Prolia $73.94Zenpep $70.06Hetlioz $67.26Fanapt $67.26Azstarys $66.39Emgality $60.11Farxiga $59.71Flucelvax $54.96Fluad $54.96Eliquis $52.85Arexvy $50.80Vaxelis $49.94Gardasil $48.99Quviviq $47.70Dexcom G6 Transmitter $47.01Xarelto $44.46Ajovy $40.79Aptima $39.71Cleerly Ischemia $37.64Cleerly Labs $37.64Prolastin-C Liquid $35.20M-M-R II $34.67Vaxneuvance $34.54Krystexxa $34.47Abrysvo $34.07Prevnar 20 $34.07Edwards Sapien 3 Transcatheter Heart Valve (Thv) $29.94Fasenra $29.63Austedo Xr $29.53Proclaim $27.47Leqvio $26.35Eterna $26.01Caplyta $25.88Strensiq $25.66Kisunla $25.38Nexplanon $23.84Glassia $23.68Impella $23.35Purified Cortrophin Gel $23.00Gvoke Hypopen $22.28General - Therapies $22.05Smartvest $21.03Enflonsia $20.59Korlym $20.41Thinprep 2000 Processor $19.59Bd Onclarity $18.72Spravato $18.47Proquad $17.81Ffrct $17.78Tirosint $17.64Licart $17.64Flector $17.64Reyvow $17.25Dupixent $16.83Uptravi $16.63Opsumit $16.63Freestyle Libre 2 $14.42Paragard T 380a $12.82Soliqua 100/33 $12.72Core Cognitive Evaluation $12.04
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.